Ipsogen, Inc Company Profile

03:56 EDT 22nd June 2018 | BioPortfolio

Ipsogen foresees cancer, the second leading cause of death in developed countries, as a unique domain where drug development, commercialisation and prescription can benefit from biomarker discovery, validation and use as companion diagnostics:

• Cancer patients require accurate assessment of their disease to optimise the use of existing drugs and to access new innovative targeted therapies.
• Oncologists urgently need new tests to guide and optimise clinical decisions to select between existing and new therapeutic options.
• Biopharmaceutical companies look to decrease the costs and the associated risks of anti cancer drug development by selecting the patients most likely to respond to a given drug in clinical trials.
From its inception in 1999, Ipsogen has developed and commercialised unique molecular tools for patient risk stratification, to predict patient response to treatment and to monitor minimal residual disease for haematological malignancies. From this proof of concept, Ipsogen is now leveraging its expertise to address unmet medical needs for solid tumours.

As a diagnostic company in oncology, Ipsogen integrates the whole value chain from biomarker discovery to development, validation and registration of accurate diagnostic tools that will help physicians drive prescription and monitor residual disease.


83 Maple Avenue
United States of America


Phone: 1 860 298 0234
Fax: 1 860 298 8586

News Articles [3 Associated News Articles listed on BioPortfolio]

FDA Approves First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms

Hilden, Germany, and Germantown, Maryland, January 23, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (i...

QIAGEN erhält FDA-Freigabe für ersten JAK2-Test als Diagnostikum für zusätzliche myeloproliferative Neoplasien

Hilden, Deutschland, und Germantown, Maryland (USA) (ots) - Der erweiterte Anwendungsbereich des ipsogen-Tests erfüllt die diagnostischen Testanforderungen der aktuellen WHO-Leitlinien für alle mye....

FDA clears expanded use of Qiagen's myeloproliferative neoplasm assay

Qiagen's Ipsogen JAK2 RGQ PCR Kit was cleared by the FDA for diagnosing two more types of myeloproliferative neoplasms, namel -More- 

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Ipsogen, Inc

Ipsogen foresees cancer, the second leading cause of death in developed countries, as a unique domain where drug development, commercialisation and prescription can benefit from biomarker discovery, v...

Ipsogen SA

More Information about "Ipsogen, Inc" on BioPortfolio

We have published hundreds of Ipsogen, Inc news stories on BioPortfolio along with dozens of Ipsogen, Inc Clinical Trials and PubMed Articles about Ipsogen, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsogen, Inc Companies in our database. You can also find out about relevant Ipsogen, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record